Print Page   |   Contact Us   |   Your Cart   |   Report Abuse   |   Sign In   |   Apply for NAQC Membership
Site Search
Sign up for NAQC membership today!

Receive a monthly issue of Connections!
NAQC Newsroom: NAQC News

September 13 Webinar: VARENICLINE (CHANTIX) CLINICAL UPDATE: Important information for Quitlines and

Friday, August 11, 2017  
Posted by: Natalia Gromov

During this webinar Pfizer Scientist, Micheal Dutro, PharmD will discuss relevant new published clinical information on varenicline. Specific topics to be discussed during this webinar include: 

  • Important recent updates to the US Chantix Label and the supporting studies:
    • EAGLES Study: Landmark trial evaluating  safety and efficacy of smoking cessation medications in smokers with and without psychiatric disease
    • Gradual Quit Study:  evaluating  a new method to quit with varenicline
    • Safety Updates
  • Using lower doses of varenicline: effect on efficacy and tolerability
  • Varenicline in a Quitline setting
» learn more


Sign In
Sign In securely
Latest News
Calendar

Membership 11 years!.

    3219 E. Camelback Road, #416, Phoenix, AZ 85018 | Ph: 800.398.5489 | Fax: 800.398.5489 | email:naqc@naquitline.org